A new Bloomberg-Feroot investigation finds that 9 of the 10 largest US health companies still load advertising trackers on patient login and registration pages.
Trentino-based Smartness tech travel startup has just raised €47 million Series B, to scale its AI operations.
Cerebras filed an updated prospectus targeting a $3.5bn raise at a $26.6bn valuation, well below the $40bn figure circulating last week.
OpenAI has finalised The Deployment Company, a $10bn joint venture with TPG, Brookfield, Bain, and 16 other investors.
Blackstone Digital Infrastructure Trust is seeking to raise up to $1.75bn in a NYSE IPO, packaging hyperscaler-leased AI data centres as a public REIT.
Palantir reports Q1 earnings under unusual pressure, after a 30% drawdown driven by Anthropic competition concerns and broader AI software multiple compression.
UCB will pay up to $2.2bn for Candid Therapeutics, betting on cizutamig and the wider T-cell engager rush in autoimmune disease.
SK Hynix shares jumped 12% as Big Tech reaffirmed plans to spend up to $725bn on AI infrastructure, deepening the memory-chip supercycle.
Anthropic is finalising a $1.5bn joint venture with Blackstone, Hellman & Friedman, Goldman Sachs, and General Atlantic to deploy Claude across PE portfolio companies.
China's $184B in AI VC, 86% of Made in China 2025 targets met, R&D spending surpassing the US. The real driver is commercialisation at scale, not government funding.
Lingyi iTech, Lens Technology, and Foxconn are repurposing smartphone factories for humanoid robots. Morgan Stanley doubled its 2026 China forecast to 28,000 units.
Beijing-based Linkerbot, the global leader in dexterous robot hands, is targeting a $6bn valuation just weeks after closing $3bn round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results